Related Experiment Video
Updated: May 11, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Heart failure presenting as myxedema coma: case report and review article
Dhara Chaudhari1, Venkat Gangadharan, Terry Forrest
1Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37615, USA. chaudharidhara@yahoo.com
Hypothyroidism, a common endocrine disorder, requires consistent treatment and patient adherence to prevent severe complications like Myxedema Coma. Untreated hypothyroidism can lead to life-threatening cardiovascular issues.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Hypothyroidism is a prevalent endocrine disorder characterized by insufficient thyroid hormone production.
- Effective management relies on timely diagnosis, consistent patient medication compliance, and regular medical follow-up.
- Delayed diagnosis or poor adherence can precipitate severe health crises.
Observation:
- Untreated hypothyroidism can progress to serious, life-threatening conditions.
- Myxedema Coma represents an extreme manifestation of severe hypothyroidism.
- Cardiovascular complications are particularly severe and pose a significant threat to life.
Findings:
- The abstract highlights the critical link between hypothyroidism management and patient outcomes.
- It emphasizes that cardiovascular manifestations are a major concern in severe or untreated cases.
- The potential for severe, life-threatening cardiovascular events underscores the importance of adherence and follow-up.
Implications:
- Highlights the critical need for improved patient education and adherence strategies in hypothyroidism management.
- Underscores the importance of early diagnosis and consistent treatment to mitigate severe cardiovascular risks.
- Reinforces the role of regular monitoring in preventing the progression to myxedema coma and associated cardiovascular emergencies.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
